2019
DOI: 10.1007/164_2019_216
|View full text |Cite
|
Sign up to set email alerts
|

Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: Inhibitors of PLD at the Crossroads of Phospholipid Biology and Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 151 publications
0
4
0
Order By: Relevance
“…45 However, the mechanism of recycling arrest under the PA/PDE4/ PKA pathway and the participation of p38 and ERK1/2 remains to be elucidated. Indeed, the complexity of PA and PLD roles in a variety of cellular processes, including cancer progression, 29,32,33 would predict other yet unknown effects of increasing PA levels with drugs such as propranolol.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…45 However, the mechanism of recycling arrest under the PA/PDE4/ PKA pathway and the participation of p38 and ERK1/2 remains to be elucidated. Indeed, the complexity of PA and PLD roles in a variety of cellular processes, including cancer progression, 29,32,33 would predict other yet unknown effects of increasing PA levels with drugs such as propranolol.…”
Section: Discussionmentioning
confidence: 99%
“…[29][30][31] PLD and PA has been involved in a variety of cellular processes and cancer progression. 29,32,33 Among the proteins that bear a PA-binding domain and become stimulated by PA-binding are type 4 phosphodiesterases (PDE4), the main regulators of cAMP levels. 31,34 Drugs such as propranolol that inhibit PAP activity and impede PA hydrolysis has been used as PAP inhibitor in vesicular trafficking studies to assess the role of DAG in the generation of vesicular carriers.…”
mentioning
confidence: 99%
“…A key complement to tools for visualizing spatiotemporally distinct pools of PA are approaches for perturbing these pools, with the goal of ascribing specific biological functions to them. Useful tools for loss-of-function studies include PLD knockout and a panel of potent pharmacological inhibitors of PLDs, both pan and isoform-selective (19,47). Such tools allow identification of scenarios where PLD-mediated PA is necessary for downstream events.…”
Section: Controlling Pa Signaling With Light Using Optogenetic Plds A...mentioning
confidence: 99%
“…Small-molecule J o u r n a l P r e -p r o o f inhibitors act more rapidly than genetic manipulations such as gene knockdown and knockout, and they can have better orthogonality by separating catalytic functions of target enzymes from noncatalytic roles (e.g., protein-protein interactions). In the realm of PA metabolism, isoformselective PLD inhibitors (19) and protein-based fluorescent PA-binding probes (20)(21)(22) are useful tools to understand loss-of-function effects of specific PA pools and to visualize the total cellular population of PA. However, these tools alone do not have enough specificity to answer several important questions: Where are PLD-derived pools of PA, as opposed to pools made by other routes, synthesized?…”
Section: Introductionmentioning
confidence: 99%